Abstract B098: An integrated fragment approach yields ABBV-973, a potent, pan-allele small molecule STING agonist for intravenous administration
Year: 2025
Type: conference-abstract
Source: Cancer Immunology Research
Authors: Kenneth D Bromberg, Douglas E Kline, Tanushree Samanta, Zhiqin Ji, Min Cheng, Sven Malchow, Jennifer Gruber, Debra Ferguson, Heath Smith, Chaohong Sun, Albert Lai, Andrew Judd
Institution: AbbVie (United States)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4407866486